[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Intensity Therapeutics Inc (INTS)

Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,288
  • Shares Outstanding, K 3,265
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,610 K
  • EBIT $ -11 M
  • EBITDA $ -11 M
  • 60-Month Beta 2.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.94
  • Number of Estimates 2
  • High Estimate $-0.77
  • Low Estimate $-1.11
  • Prior Year $-1.50
  • Growth Rate Est. (year over year) +37.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.90 +4.59%
on 08/14/26
5.17 -21.08%
on 08/25/26
-0.07 (-1.69%)
since 07/31/26
3-Month
3.51 +16.24%
on 06/09/26
5.17 -21.08%
on 08/25/26
-0.20 (-4.67%)
since 06/02/26
52-Week
3.51 +16.24%
on 06/09/26
43.50 -90.62%
on 10/30/25
-2.80 (-40.65%)
since 09/02/25

Most Recent Stories

More News
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Conference call begins at 8:00 a.m. Eastern time today

INTS : 4.08 (+0.25%)
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026

Company to hold a conference call at 8AM ET on August 11, 2026 to review results and provide a corporate update

INTS : 4.08 (+0.25%)
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)

First patients dosed in Switzerland

INTS : 4.08 (+0.25%)
Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

SHELTON, Conn. , July 1, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...

INTS : 4.08 (+0.25%)
Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award

Company receives the Cancer Treatment Technology Innovator of the Year award

INTS : 4.08 (+0.25%)
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

SHELTON, Conn. , May 7, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...

INTS : 4.08 (+0.25%)
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation

Company receives the Platinum Award for Innovator in Biotech Solutions Category

INTS : 4.08 (+0.25%)
Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update

SHELTON, Conn. , March 27, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...

INTS : 4.08 (+0.25%)
Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US

SHELTON, Conn. , March 24, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. , (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery...

INTS : 4.08 (+0.25%)
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study

SHELTON, Conn. , March 12, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and...

INTS : 4.08 (+0.25%)

Business Summary

Intensity Therapeutics Inc. is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx(SM) technology platform to create new, proprietary drug formulations, following direct injection, rapidly disperse throughout a tumor...

See More

Key Turning Points

3rd Resistance Point 4.32
2nd Resistance Point 4.25
1st Resistance Point 4.16
Last Price 4.08
1st Support Level 4.00
2nd Support Level 3.93
3rd Support Level 3.84

See More

52-Week High 43.50
Fibonacci 61.8% 28.22
Fibonacci 50% 23.50
Fibonacci 38.2% 18.79
Last Price 4.08
52-Week Low 3.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.